european medicines agency glp-1 vision loss recommendation november 2025 ISPOR 2025: Exploring reasons for discontinuation EMA finds no link between

Keeping your body hydrated is critical on GLP-1 medicatio

Backed by more than five years of real-world clinical data, Calibrate members achieve an average of 18% weight loss at one year and sustain these results over the long term, far exceeding outcomes from medication alone

Drawing from U.S

Learn about different types, how they work, and side effects in this complete guide reviewed by medical experts.

A comprehensive review of the literature was conducted to examine the etiology of HFpEF, the role of endothelial dysfunction, and the effects of GLP-1R agonists on endothelial function and heart failure outcomes

June 2, 2026 Results of an American College of Radiology-managed retrospective study involving 110,000 womenpresented at the 2026 ASCO Annual Meeting, shows that those who took GLP-1 medications were up to 35% less likely to develop breast cancer than those who did not take GLP-1 drugs. ACR urges funding of a large prospective study to clarify impact of these drugs on cancer incidence and prevention.